AEST.MED.INT.HLD.SP.ADR/3 Cash Flow Reinvestment Rate
AEST.MED.INT.HLD.SP.ADR/3 cash flow reinvestment rate. AEST.MED.INT.HLD.SP.ADR/3 (3FMA) has a Cash Flow Reinvestment Rate of 0.39x as of December 2024, reinvesting €30.79 Million (capex €30.79 Million ) from operating cash flow of €79.67 Million. Explore 3FMA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of AEST.MED.INT.HLD.SP.ADR/3 (2021–2024)
Cash flow reinvestment rate of AEST.MED.INT.HLD.SP.ADR/3 from 2021 to 2024. Historical reinvestment intensity for AEST.MED.INT.HLD.SP.ADR/3 across 3 annual periods. Explore how much does AEST.MED.INT.HLD.SP.ADR/3 reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
AEST.MED.INT.HLD.SP.ADR/3 Cash Flow Reinvestment Rate by Year (2021–2024)
AEST.MED.INT.HLD.SP.ADR/3 cash flow reinvestment rate by year from 2021 to 2024. Year-by-year capital reinvestment analysis for AEST.MED.INT.HLD.SP.ADR/3. For the full cash flow conversion analysis, see 3FMA cash flow metrics.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.39x | €30.79 Million | €79.67 Million | €30.79 Million | ▼ -48.2% |
| 2023 | 0.75x | €55.46 Million | €74.29 Million | €55.46 Million | ▲ +14.1% |
| 2021 | 0.65x | €33.44 Million | €51.09 Million | €33.44 Million | — |